We are writing to inform you that Bausch + Lomb Corporation (NYSE/TSX: BLCO) has completed its acquisition of XIIDRA® (lifitegrast ophthalmic solution). Bausch + Lomb now owns and markets XIIDRA. In order to provide uninterrupted service, for XIIDRA, Novartis Pharmaceuticals Corporation will service the copay assistance and patient support programs until March 31, 2024.
If you need to refill your XIIDRA prescription before March 31, 2024, please present the information below to your pharmacy instead of using your existing copay card.
The card details below expire on July 1, 2024, at which time you will need to re-enroll in the Bausch + Lomb sponsored copay program (enrollment information below).
RxBIN: 019158
RxPCN: CNRX
RxGroup: AC41707001
ID: 29933150708
After March 31, 2024, you will need to re-enroll in the program directly with Bausch + Lomb. You may re-enroll into the XIIDRA copay program by visiting xiidra.copaysavingsprogram.com or calling 1-877-4-XIIDRA (1-877-494-4372). Should you have any questions, feel free to contact the XIIDRA copay support line at 1-877-4-XIIDRA.
By using your Xiidra copay card, you agree to the Bausch + Lomb terms and conditions:
By using the XIIDRA My Savings Program, you confirm that you understand and agree to comply with the following Terms and Conditions of this offer: